Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
Status:
Completed
Trial end date:
2017-09-29
Target enrollment:
Participant gender:
Summary
Primary objective:
To assess the efficacy of I10E in improving the disability of patients with CIDP.
Secondary objective:
To assess the safety of I10E in patients with CIDP.
Phase:
Phase 3
Details
Lead Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies